Senior Investigator,
Chief, Laboratory of Cardiovascular Intervention
National Institutes of Health/National Heart, Lung, and Blood Institute
Bethesda, Maryland, United States
Dr Lederman is the chief of the Laboratory of Cardiovascular Intervention at the NHLBI Division of Intramural Research in Bethesda Maryland USA. His program creates new catheter based treatments and devices for structural heart disease and introduces them into medical practice. His multidisciplinary team includes adult and pediatric interventional cardiologists, imaging physicists, and biomedical engineers. The NHLBI Lederman lab has invented and translated into clinical practice numerous structural heart procedures including transcaval access to the aorta; mitral cerclage annuloplasty; LAMPOON, ELASTIC, and BASILICA leaflet modification to allow TMVR and TAVR, transcatheter cavopulmonary shunt creation, and MRI heart catheterization. These procedures and protocols are possible though a network of luminary collaborating structural heart interventional cardiologists.
Disclosure information not submitted.
CRT 2024 | Faculty Assignment [ADJ]
Saturday, March 9, 2024
9:00 AM – 9:00 PM ET
SESAME A Novel Treatment for HOCM
Monday, March 11, 2024
3:44 PM – 3:52 PM ET
Monday, March 11, 2024
4:48 PM – 5:15 PM ET
DEVICES TO PREVENT CORONARY OBSTRUCTION AND ENABLERS OF LIVE MANAGEMENT
Tuesday, March 12, 2024
8:00 AM – 8:58 AM ET
Telltale (BASILICA) Technology and Clinical Trials Update
Tuesday, March 12, 2024
8:16 AM – 8:24 AM ET
Panel Discussion | Can we Prevent Coronary Obstruction Post TAVR?
Tuesday, March 12, 2024
8:32 AM – 8:58 AM ET